Exploit COVID-19 Studies with Creative Biolabs’ Neutralizing Antibodies

Creative Biolabs launches a specialized portfolio of neutralizing antibodies to support research on viral infections, especially the COVID-19 that is hurting the whole world. Resourceful antibodies accompanied by professional technical support are ready for shipment.

New York, USA – September 11, 2020 – According to the latest update on September 10th, the figure of COVID-19 confirmed cases has reached 27.8M worldwide, with 902K deaths, and is still climbing. By now, no vaccine or drug has completed clinical trials, and some have even not entered the clinical stage. Recently, researchers in the medical industry discovered that neutralizing antibodies can make progress in the research on therapeutic methods of pneumonia caused by SARS-CoV-2. Neutralizing antibodies are produced by the immune system after being attacked to couple with the virus and thereby defend human cells, which can trigger long-term immunity. As an expert in the field of antibody development, Creative Biolabs has instantly responded to the COVID-19 pandemic, and successfully developed resourceful high-standard products that are readily available for delivery.

SARS-CoV-2 Related Antibody Products

Creative Biolabs has categorized its antibody products into several groups according to different targets, which are crucial genes on the surface of SARS-CoV-2.

SARS-CoV-2 S neutralizing antibodies:

* Anti-SARS-CoV-2 Spike S2 Antibodies
* Anti-SARS-CoV-2 Spike RBD Antibodies

Other targets:

* Anti-SARS-CoV Matrix Protein Antibodies
* Anti-SARS-CoV Nucleocapsid Protein Antibodies
* Anti-SARS-CoV Spike Protein Antibodies
* Anti-SARS-CoV E glycoprotein (E1 or E2) Antibodies
* Anti-ACE2 Antibodies
* Anti-CD147 Antibodies

In addition to the above-mentioned antibody products, there are also other product types for research use, to fulfill all possible requirements from clients.

SARS-CoV-2 PCR Detection Kit: based on the fluorogenic 5’nuclease assay to detect SARS-CoV-2 with real-time PCR systems.
SARS-CoV-2 IgM/IgG Kit: detect IgG and IgM antibodies against SARS-CoV-2 in patients’ serum, plasma, or whole blood through lateral flow immunoassay.
SARS-CoV-2 CRISPR Diagnostics: detect SARS-CoV-2 target sequences in a range from 20 and 200 aM based upon the CRISPR-based SHERLOCK (Specific High Sensitivity Enzymatic Reporter UnLOCKing) technique.
ACE2 Activity Assay Kit: aim at angiotensin-converting enzyme 2.
ACE2 Inhibitor Screening Kit: detect potent inhibitors of ACE2 activity.

Based upon the unparalleled skill in mammalian cell (293F or CHO) transient transfection and powerful transient transfection platform, Creative Biolabs can design and develop high standard neutralizing antibodies according to individual requests, including a variety of primary antibodies, secondary antibodies, and isotype controls, which can be applied to the design of new vaccines and molecule drugs.

More details about the professional capabilities and scope of neutralizing antibody services can be accessed at https://neutab.creative-biolabs.com.

About Creative Biolabs

Creative Biolabs is a team specialized in life science technologies, not only offering solutions regarding antibody discovery, development, and engineering but also distributing high-quality products to worldwide clients. Since establishment, scientists at Creative Biolabs have been working on therapeutic antibodies for the discovery of novel drugs. Since the outbreak of SARS-CoV-2, those scientists immediately responded to deal with the pandemic, leveraged useful resources, and organized a team that provides specialized solutions about neutralizing antibody.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://neutab.creative-biolabs.com